These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 33982858)

  • 41. Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression.
    Hermansen TK; Røysamb E; Augusti EM; Melinder A
    Psychopharmacology (Berl); 2016 Apr; 233(8):1523-35. PubMed ID: 26924747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Antidepressant Medication Use During Pregnancy With Intellectual Disability in Offspring.
    Viktorin A; Uher R; Kolevzon A; Reichenberg A; Levine SZ; Sandin S
    JAMA Psychiatry; 2017 Oct; 74(10):1031-1038. PubMed ID: 28700807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antidepressant use during pregnancy and asthma in the offspring.
    Liu X; Olsen J; Pedersen LH; Agerbo E; Yuan W; Li J
    Pediatrics; 2015 Apr; 135(4):e911-7. PubMed ID: 25755245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prenatal Antidepressant Exposure and the Risk of Attention-Deficit/Hyperactivity Disorder in Childhood: Accounting for Misclassification of Exposure.
    Esen BÖ; Ehrenstein V; Nørgaard M; Sørensen HT; Pedersen L
    Epidemiology; 2023 Jul; 34(4):476-486. PubMed ID: 36976730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genome-wide DNA methylation in neonates exposed to maternal depression, anxiety, or SSRI medication during pregnancy.
    Non AL; Binder AM; Kubzansky LD; Michels KB
    Epigenetics; 2014 Jul; 9(7):964-72. PubMed ID: 24751725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maternal Fiber Intake During Pregnancy and Development of Attention-Deficit/Hyperactivity Disorder Symptoms Across Childhood: The Norwegian Mother, Father, and Child Cohort Study.
    Solberg BS; Kvalvik LG; Instanes JT; Hartman CA; Klungsøyr K; Li L; Larsson H; Magnus P; Njølstad PR; Johansson S; Andreassen OA; Bakken NR; Bekkhus M; Austerberry C; Smajlagic D; Havdahl A; Corfield EC; Haavik J; Gjestad R; Zayats T
    Biol Psychiatry; 2024 May; 95(9):839-848. PubMed ID: 38142720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden.
    Zoega H; Kieler H; Nørgaard M; Furu K; Valdimarsdottir U; Brandt L; Haglund B
    PLoS One; 2015; 10(12):e0144474. PubMed ID: 26657647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study.
    Lupattelli A; Spigset O; Koren G; Nordeng H
    J Clin Psychopharmacol; 2014 Feb; 34(1):143-8. PubMed ID: 24135843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Body mass index and childhood symptoms of depression, anxiety, and attention-deficit hyperactivity disorder: A within-family Mendelian randomization study.
    Hughes AM; Sanderson E; Morris T; Ayorech Z; Tesli M; Ask H; Reichborn-Kjennerud T; Andreassen OA; Magnus P; Helgeland Ø; Johansson S; Njølstad P; Davey Smith G; Havdahl A; Howe LD; Davies NM
    Elife; 2022 Dec; 11():. PubMed ID: 36537070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications.
    Viguera AC; McElheny SA; Caplin PS; Kobylski LA; Rossa ET; Young AV; Gaccione P; Góez-Mogollón L; Freeman MP; Cohen LS
    J Clin Psychiatry; 2023 Jan; 84(1):. PubMed ID: 36602927
    [No Abstract]   [Full Text] [Related]  

  • 52. Behavioural effects of fetal antidepressant exposure in a Norwegian cohort of discordant siblings.
    Brandlistuen RE; Ystrom E; Eberhard-Gran M; Nulman I; Koren G; Nordeng H
    Int J Epidemiol; 2015 Aug; 44(4):1397-407. PubMed ID: 25873178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitors and epidemiological characteristics associated with prenatal diagnosis of congenital heart disease.
    Melov SJ; Shetty PS; Pasupathy D; Kirby A; Sholler GF; Winlaw DS; Alahakoon TI
    Prenat Diagn; 2021 Jan; 41(1):35-42. PubMed ID: 33067884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system.
    Clements CC; Castro VM; Blumenthal SR; Rosenfield HR; Murphy SN; Fava M; Erb JL; Churchill SE; Kaimal AJ; Doyle AE; Robinson EB; Smoller JW; Kohane IS; Perlis RH
    Mol Psychiatry; 2015 Jun; 20(6):727-34. PubMed ID: 25155880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prenatal antibiotic exposure and risk of attention-deficit/hyperactivity disorder: a population-based cohort study.
    Hamad AF; Alessi-Severini S; Mahmud S; Brownell M; Kuo IF
    CMAJ; 2020 May; 192(20):E527-E535. PubMed ID: 32575031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Associations Between Pregnancy-Related Predisposing Factors for Offspring Neurodevelopmental Conditions and Parental Genetic Liability to Attention-Deficit/Hyperactivity Disorder, Autism, and Schizophrenia: The Norwegian Mother, Father and Child Cohort Study (MoBa).
    Havdahl A; Wootton RE; Leppert B; Riglin L; Ask H; Tesli M; Bugge Askeland R; Hannigan LJ; Corfield E; Øyen AS; Andreassen OA; Tilling K; Davey Smith G; Thapar A; Reichborn-Kjennerud T; Stergiakouli E
    JAMA Psychiatry; 2022 Aug; 79(8):799-810. PubMed ID: 35793100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study.
    Kolding L; Ehrenstein V; Pedersen L; Sandager P; Petersen OB; Uldbjerg N; Pedersen LH
    BJOG; 2021 Nov; 128(12):1949-1957. PubMed ID: 34036715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-Term Maternal and Child Outcomes Following Postnatal SSRI Treatment.
    Liu C; Ystrom E; McAdams TA
    JAMA Netw Open; 2023 Aug; 6(8):e2331270. PubMed ID: 37642961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of antidepressants in pregnancy: focus on maternal risks.
    Gadot Y; Koren G
    J Obstet Gynaecol Can; 2015 Jan; 37(1):56-63. PubMed ID: 25764038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations.
    Morales DR; Slattery J; Evans S; Kurz X
    BMC Med; 2018 Jan; 16(1):6. PubMed ID: 29332605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.